$CLX, $CVS, $KMB
We here at HeffX-LTN have been looking at companies that are doing well now as a result of this unprecedented situation the US and the world is in, the coronavirus pandemic.
We picked 3 stocks out of the lot that are doing very well and still could be a safe place for anxious investors.
All 3 are rated Buy at Top Wall Street firms, they are the following:
Clorox: bleach has been in demand, and so are the other products this company sells. Clorox Co. (NYSE:CLX) is a diversified manufacturer and marketer of household products, specialty food items and pet care items. Well-known brands include Tilex, Liquid Plumr, 409, Pine-Sol, Kingsford, Glad, Brita, Hidden Valley, KC Masterpiece, Burt’s Bees and Fresh Step.
Investors receive a 2.06% dividend. JPMorgan recently upgraded it to Overweight with a 185 price target. The Wall Street consensus target is 157.92, but Clorox stock has blown through those marks, last seen at 191.87.
CVS:This top stock may still be offering an excellent entry point. CVS Health Corporation (NYSE:CVS) is one of the largest health care companies in the United States, providing retail, mail and specialty pharmacy dispensing services and pharmacy benefits. Upon the completion of its acquisition of health care giant Aetna, CVS became one of the most vertically integrated publicly traded healthcare companies.
Investors receive a 3.45% dividend. Merrill Lynch has set an 86 price target for the shares, which compares with the consensus target of 84.25. CVS Health stock was last seen trading at 55.38/share.
Kimberly-Clark: This tumultuous time will be remembered for the run on toilet paper, and the empty shelves, and this company should be a big winner. Kimberly-Clark Corp. (NYSE:KMB) is a manufacturer of tissue, personal care, and health care products. Global brands include Huggies, Kotex, Kleenex, Cottonelle, Viva, Scott, Depend and Poise, as well as Andrex in the United Kingdom.
The company also raised its dividend for Y 2020 by 3.9% to 1.07/ share. The dividend increase now means a tempting 3.18% yield. The 155 Merrill Lynch price objective is above the 141.15 consensus price target. Last seen at 126.41.
Have a healthy day